Urgent.News

What's breaking now, across thousands of outlets.

Business

When “good enough” becomes a competitive disadvantage: The case for quantum optimization

Manufacturers may be meeting production requirements but sacrificing capacity, responsiveness and margin to the limitations of their planning tools.

We haven't written up this one. Manufacturing Dive has the full story — the link below goes straight to it.

Read the original at manufacturingdive.com →

More in Business

Medytox Gains NMPA Approval for NEURAMIS Filler

Medytox said on Sept. 28, that it has obtained product approval from China’s National Medical Products Administration (NMPA) for the hyaluronic acid filler “NEURAMIS Volume Lidocaine.”In addition to…

  • Medytox received NMPA approval for NEURAMIS Volume Lidocaine on September 28
  • NEURAMIS is a hyaluronic acid filler with reduced BDDE for lower side effects risk
  • Company targets China's growing aesthetic market for NEURAMIS launch by Q4

More from Monday 28 September →